Lsv Asset Management Vertex Pharmaceuticals Inc Transaction History

Lsv Asset Management

  • $46.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$234.96 - $292.55 $164,472 - $204,785
-700 Reduced 14.73%
4,051 $1.14 Million
Q1 2022

May 12, 2022
BUY
$221.42 - $260.97 $708,544 - $835,104
3,200 Added 206.32%
4,751 $1.24 Million
Q4 2021

Jan 28, 2022
BUY
$177.01 - $223.45 $274,542 - $346,570
1,551 New
1,551 $341,000

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Lsv Asset Management Portfolio

Follow Lsv Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email